HZNP logo

HZNP Selling, General & Administrative Expenses

Annual SGA

$1.54 B
+$94.64 M+6.54%

December 31, 2022

Summary

Performance

1-Year Change

+6.54%

3-Year Change

+121.06%

5-Year Change

+135.24%

15-Year Change

+135.24%

HZNP SGA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

All-time High

$1.54 B
HZNP annual SGA is currently at an all-time high

3-Year Low

$1.45 B
HZNP annual SGA is currently +6.54% above its 3-year low

Earnings dates

Last Annual Earnings Report Date

Dec 31, 2022
HZNP previous annual earnings announcement was published on Dec 31, 2022

Next Annual Earnings Report Date

N/A
HZNP next annual earnings announcement has not yet been scheduled

OtherHZNPexpensesmetrics:

Annual Total Expenses

$2.90 B
HZNP annual total expenses is $2.90 billion

Annual Operating Expenses

$1.98 B
HZNP annual total operating expenses is $1.98 billion

Annual Cost Of Goods Sold

$920.20 M
HZNP annual cost of goods sold is $920.20 million

Annual Interest Expense

$83.71 M
HZNP annual interest expense is $83.71 million

Quarterly SGA

$434.13 M
-$19.23 M-4.24%

June 30, 2023

Summary

Performance

3-Month Change

-4.24%

1-Year Change

+9.02%

3-Year Change

+95.26%

5-Year Change

+145.72%

HZNP Quarterly SGA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

All-time High

$453.35 M
HZNP quarterly SGA is currently -4.24% below its historical high of $453.35 million

3-Year Low

$372.53 M
HZNP quarterly SGA is currently +16.53% above its 3-year low

Earnings dates

Last Quarterly Earnings Report Date

Jun 30, 2023
HZNP previous earnings announcement was published on Jun 30, 2023

Next Quarterly Earnings Report Date

N/A
HZNP next earnings announcement has not yet been scheduled

OtherHZNPexpensesmetrics:

Quarterly Total Expenses

$804.12 M
HZNP quarterly total expenses is $804.12 million

Quarterly Operating Expenses

$584.16 M
HZNP quarterly total operating expenses is $584.16 million

Quarterly Cost Of Goods Sold

$219.96 M
HZNP quarterly cost of goods sold is $219.96 million

Quarterly Interest Expense

$12.10 M
HZNP quarterly interest expense is $12.10 million

TTM SGA

$2.61 B
+$187.92 M+7.75%

June 30, 2023

Summary

Performance

3-Month Change

+61.11%

1-Year Change

+70.75%

3-Year Change

+215.62%

5-Year Change

+274.8%

HZNP TTM SGA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

All-time High

$2.61 B
HZNP TTM SGA is currently at an all-time high

3-Year Low

-$56.33 M

Earnings dates

Last Quarterly Earnings Report Date

Jun 30, 2023
HZNP previous earnings announcement was published on Jun 30, 2023

Next Quarterly Earnings Report Date

N/A
HZNP next earnings announcement has not yet been scheduled

OtherHZNPexpensesmetrics:

Annual Total Expenses

$2.90 B
HZNP annual total expenses is $2.90 billion

Annual Operating Expenses

$1.98 B
HZNP annual total operating expenses is $1.98 billion

TTM Cost Of Goods Sold

$903.44 M
HZNP TTM cost of goods sold is $903.44 million

TTM Interest Expense

$68.68 M
HZNP TTM interest expense is $68.68 million

Selling, General & Administrative Expenses Formula

SGA = Total Operating Expenses - Cost of Goods Sold - Research & Development

Annual SGA

$1.54 B
HZNP annual SGA is $1.54 billion

Annual Operating Expenses

$1.98 B
HZNP annual total operating expenses is $1.98 billion

Annual Cost Of Goods Sold

$920.20 M
HZNP annual cost of goods sold is $920.20 million

HZNP Selling, General & Administrative Expenses Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+6.5%+9.0%+70.8%
3 y3 years+121.1%+95.3%+215.6%
5 y5 years+135.2%+145.7%+274.8%

HZNP Selling, General & Administrative Expenses Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-yearat high-6.1%-4.2%-14.2%at high-102.2%
5 y5-yearat high-54.8%-4.2%-57.3%at high-262.0%
alltimeall timeat high-99.7%-4.2%-99.6%at high-310.7%

Horizon Therapeutics Public Limited Selling, General & Administrative Expenses History

DateAnnualQuarterlyTTM
Jun 2023
-
$434.13 M(-4.2%)
$1.66 B(+2.2%)
Mar 2023
-
$453.35 M(+21.7%)
$1.62 B(+5.2%)
Dec 2022
$1.54 B(+6.5%)
$372.53 M(-6.3%)
$1.54 B(-1.7%)
Sep 2022
-
$397.56 M(-0.2%)
$1.57 B(+2.4%)
Jun 2022
-
$398.22 M(+6.8%)
$1.53 B(+2.9%)
Mar 2022
-
$372.73 M(-6.6%)
$1.49 B(+2.8%)
Dec 2021
$1.45 B(+48.6%)
$398.95 M(+10.7%)
$1.45 B(+9.2%)
Sep 2021
-
$360.26 M(+1.4%)
$1.32 B(+11.3%)
Jun 2021
-
$355.20 M(+7.0%)
$1.19 B(+12.6%)
Mar 2021
-
$331.99 M(+19.9%)
$1.06 B(+8.7%)
Dec 2020
$973.23 M(+39.6%)
$276.96 M(+22.5%)
$973.23 M(+10.4%)
Sep 2020
-
$226.16 M(+1.7%)
$881.66 M(+6.5%)
Jun 2020
-
$222.33 M(-10.3%)
$827.82 M(+7.1%)
Mar 2020
-
$247.78 M(+33.6%)
$772.59 M(+10.8%)
Dec 2019
$697.11 M(+0.7%)
$185.39 M(+7.6%)
$697.11 M(+1.6%)
Sep 2019
-
$172.33 M(+3.1%)
$686.35 M(+1.6%)
Jun 2019
-
$167.09 M(-3.0%)
$675.61 M(-1.4%)
Mar 2019
-
$172.30 M(-1.3%)
$685.18 M(-1.1%)
Dec 2018
$692.49 M(+5.7%)
$174.63 M(+8.1%)
$692.49 M(+1.1%)
Sep 2018
-
$161.59 M(-8.5%)
$685.28 M(+1.1%)
Jun 2018
-
$176.67 M(-1.6%)
$677.65 M(+2.6%)
Mar 2018
-
$179.60 M(+7.3%)
$660.63 M(+0.8%)
Dec 2017
$655.09 M(+8.6%)
$167.42 M(+8.8%)
$655.09 M(-4.1%)
Sep 2017
-
$153.95 M(-3.6%)
$683.15 M(+3.3%)
Jun 2017
-
$159.65 M(-8.3%)
$661.25 M(+4.1%)
Mar 2017
-
$174.06 M(-11.0%)
$635.17 M(+5.3%)
Dec 2016
$603.05 M
$195.49 M(+48.0%)
$603.05 M(+13.2%)
Sep 2016
-
$132.05 M(-1.1%)
$532.79 M(+5.0%)
Jun 2016
-
$133.57 M(-5.9%)
$507.23 M(-0.3%)
DateAnnualQuarterlyTTM
Mar 2016
-
$141.94 M(+13.3%)
$508.90 M(+15.6%)
Dec 2015
$440.31 M(+110.4%)
$125.23 M(+17.6%)
$440.31 M(+18.9%)
Sep 2015
-
$106.49 M(-21.3%)
$370.40 M(+11.2%)
Jun 2015
-
$135.25 M(+84.4%)
$333.13 M(+37.3%)
Mar 2015
-
$73.34 M(+32.6%)
$242.69 M(+16.0%)
Dec 2014
$209.23 M(+127.0%)
$55.32 M(-20.1%)
$209.23 M(+15.2%)
Sep 2014
-
$69.22 M(+54.5%)
$181.60 M(+35.6%)
Jun 2014
-
$44.81 M(+12.3%)
$133.88 M(+20.9%)
Mar 2014
-
$39.89 M(+44.1%)
$110.78 M(+20.2%)
Dec 2013
$92.16 M(+33.6%)
$27.69 M(+28.8%)
$92.16 M(+9.0%)
Sep 2013
-
$21.50 M(-1.0%)
$84.58 M(+4.8%)
Jun 2013
-
$21.71 M(+2.1%)
$80.71 M(+8.9%)
Mar 2013
-
$21.27 M(+5.8%)
$74.10 M(+7.4%)
Dec 2012
$69.00 M(+95.4%)
$20.10 M(+14.0%)
$69.00 M(+4.3%)
Sep 2012
-
$17.63 M(+16.8%)
$66.16 M(+14.3%)
Jun 2012
-
$15.10 M(-6.7%)
$57.86 M(+22.4%)
Mar 2012
-
$16.18 M(-6.3%)
$47.28 M(+33.9%)
Dec 2011
$35.32 M(+46.1%)
$17.26 M(+84.9%)
$35.32 M(+44.5%)
Sep 2011
-
$9.33 M(+106.6%)
$24.44 M(+16.7%)
Jun 2011
-
$4.52 M(+7.2%)
$20.94 M(-11.3%)
Mar 2011
-
$4.21 M(-33.9%)
$23.61 M(-2.4%)
Dec 2010
$24.17 M(+206.1%)
$6.37 M(+9.2%)
$24.19 M(+22.0%)
Sep 2010
-
$5.83 M(-18.9%)
$19.83 M(+23.9%)
Jun 2010
-
$7.19 M(+50.1%)
$16.00 M(+46.4%)
Mar 2010
-
$4.79 M(+138.5%)
$10.93 M(+38.5%)
Dec 2009
$7.89 M(+72.7%)
$2.01 M(-0.1%)
$7.89 M(+34.1%)
Sep 2009
-
$2.01 M(-5.1%)
$5.89 M(+51.9%)
Jun 2009
-
$2.12 M(+20.9%)
$3.87 M(+120.9%)
Mar 2009
-
$1.75 M
$1.75 M
Dec 2008
$4.57 M
-
-

FAQ

  • What is Horizon Therapeutics Public Limited annual SGA?
  • What is the all time high annual SGA for Horizon Therapeutics Public Limited?
  • What is Horizon Therapeutics Public Limited annual SGA year-on-year change?
  • What is Horizon Therapeutics Public Limited quarterly SGA?
  • What is the all time high quarterly SGA for Horizon Therapeutics Public Limited?
  • What is Horizon Therapeutics Public Limited quarterly SGA year-on-year change?
  • What is Horizon Therapeutics Public Limited TTM SGA?
  • What is the all time high TTM SGA for Horizon Therapeutics Public Limited?
  • What is Horizon Therapeutics Public Limited TTM SGA year-on-year change?

What is Horizon Therapeutics Public Limited annual SGA?

The current annual SGA of HZNP is $1.54 B

What is the all time high annual SGA for Horizon Therapeutics Public Limited?

Horizon Therapeutics Public Limited all-time high annual SGA is $1.54 B

What is Horizon Therapeutics Public Limited annual SGA year-on-year change?

Over the past year, HZNP annual SGA has changed by +$94.64 M (+6.54%)

What is Horizon Therapeutics Public Limited quarterly SGA?

The current quarterly SGA of HZNP is $434.13 M

What is the all time high quarterly SGA for Horizon Therapeutics Public Limited?

Horizon Therapeutics Public Limited all-time high quarterly SGA is $453.35 M

What is Horizon Therapeutics Public Limited quarterly SGA year-on-year change?

Over the past year, HZNP quarterly SGA has changed by +$35.90 M (+9.02%)

What is Horizon Therapeutics Public Limited TTM SGA?

The current TTM SGA of HZNP is $2.61 B

What is the all time high TTM SGA for Horizon Therapeutics Public Limited?

Horizon Therapeutics Public Limited all-time high TTM SGA is $2.61 B

What is Horizon Therapeutics Public Limited TTM SGA year-on-year change?

Over the past year, HZNP TTM SGA has changed by +$1.08 B (+70.75%)